Therabron Therapeutics Overview

  • Founded
  • 2007
Founded
  • Status
  • Out of Business
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Out of Business

Therabron Therapeutics General Information

Description

Developer of novel drugs with therapeutic proteins designed to cure respiratory diseases. The company's novel drugs with therapeutic proteins develop a series of recombinant human secretoglobins, enabling patients to access treatments for a range of orphan and more commonplace respiratory diseases impacting people from infancy through adulthood.

Contact Information

Formerly Known As
Clarassance
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 9430 Key West Avenue
  • Suite 150
  • Rockville, MD 20850
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Therabron Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 01-Nov-2018 000.00 Completed Out of Business
7. Later Stage VC 27-Dec-2016 00.000 000.00 Completed Clinical Trials - Phase 2
6. Later Stage VC (Series B) 18-Nov-2015 00.000 000.00 Completed Generating Revenue
5. Later Stage VC 17-Jun-2014 00.000 00.000 Completed Generating Revenue
4. Grant 24-Sep-2012 00000 00000 Completed Startup
3. Angel (individual) 17-Sep-2012 00000 00000 Completed Startup
2. Angel (individual) 10-Nov-2011 $315K $315K Completed Startup
1. Grant 29-Oct-2010 $244K Completed Startup
To view Therabron Therapeutics’s complete valuation and funding history, request access »

Therabron Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000 00.000000 000.00 000.00 00 000.00 00.000
Series A4 0,000 00.000000 000 000 00 000 0.000
Series A3 00,000 00.000000 00 00 00 00 0.000
Series A2 89,683 $0.001000 $6.3 $6.3 1x $6.3 2.2%
Series A1 116,279 $0.001000 $2.15 $2.15 1x $2.15 2.85%
To view Therabron Therapeutics’s complete cap table history, request access »

Therabron Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial